Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 24 September 2021
Patients discharged on anti-platelet therapy indicator
Percentage of patients discharged on anti-platelet therapy
How is the Trust doing?
|Rolling year to date (February 2019 – January 2020)||100%|
|Rolling 3 years (February 2017 – January 2020)||99.9%|
Higher percentage indicates better performance.
The percentage of first-time, isolated CABG patients who are given anti-platelet therapy on the day of discharge remains steady over time
Why is this indicator important?
Anti-platelet drug therapy improves graft function through the prevention of clot formation for patients who have had a first-time, isolated CABG. It also helps prevent further cardiac problems.
The aim is for all eligible patients (patients for whom these drugs are suitable) to receive them on the day of discharge.
How do we measure this indicator?
The percentage of all patients admitted for first-time, isolated CABG given anti-platelet therapy (aspirin or clopidogrel) on the day of discharge.
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.